J 2024

Effect of Body Mass Index on Effectiveness of CT versus Invasive Coronary Angiography in Stable Chest Pain: The DISCHARGE Trial

SYKES, Robert; Damien COLLISON; Bela MERKELY; Klaus F KOFOED; Patrick DONNELLY et. al.

Základní údaje

Originální název

Effect of Body Mass Index on Effectiveness of CT versus Invasive Coronary Angiography in Stable Chest Pain: The DISCHARGE Trial

Autoři

SYKES, Robert; Damien COLLISON; Bela MERKELY; Klaus F KOFOED; Patrick DONNELLY; Jose RODRIGUEZ-PALOMARES; Andrejs ERGLIS; Josef VESELKA; Gintare SAKALYTE; Nada CEMERLIC; Matthias GUTBERLET; Jonathan D DODD; Ignacio DIEZ; Gershan DAVIS; Elke ZIMMERMANN; Cezary KEPKA; Radosav VIDAKOVIC; Marco FRANCONE; Malgorzata ILNICKA-SUCKIEL; Fabian PLANK; Juhani KNUUTI; Rita FARIA; Stephen SCHROEDER; Colin BERRY; Luca SABA; Balazs RUZSICS; Nina RIECKMANN; Christine KUBIAK; Kristian SCHULTZ; Jacqueline MUELLER-NORDHORN; Pal MAUROVICH-HORVAT; Andreas D KNUDSEN; Imre BENEDEK; Clare ORR; Filipa Xavier VALENTE; Ligita ZVAIGZNE; Martin HORVATH; Antanas JANKAUSKAS; Filip ADIC; Michael WOINKE; Stephen KEANE; Inigo LECUMBERRI; Erica THWAITE; Michael LAULE; Mariusz KRUK; Aleksandra ZIVANIC; Massimo MANCONE; Donata KUSMIERZ; Gudrun FEUCHTNER; Mikko PIETILAE; Vasco Gama RIBEIRO; Tanja DROSCH; Christian DELLES; Michele PORCU; Michael FISHER; Tamas BARANY; Charlotte SORUM; Rosca AURELIAN; Stephanie KELLY; Bruno Garcia del BLANCO; Ainhoa RUBIO; Balint SZILVESZTER; Jawdat ABDULLA; Ioana RODEAN; Susan REGAN; Hug Cuellar CALABRIA; Milan VECSEY-NAGY; Birgit JURLANDER; Roxana HODAS; Sarah FEGER; Mahmoud MOHAMED; Lina M SERNA-HIGUITA; Konrad NEUMANN; Henryk DREGER; Matthias RIEF; Viktoria WIESKE; Maros FERENCIK; Melanie ESTRELLA; Maria BOSSERDT; Peter MARTUS; Theodora BENEDEK a Marc DEWEY

Vydání

Radiology, Chicago, The Radiological Society of North America, 2024, 0033-8419

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30230 Other clinical medicine subjects

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 12.100 v roce 2023

Kód RIV

RIV/00216224:90034/24:00138399

Organizační jednotka

CZECRIN

UT WoS

001237073800020

Klíčová slova česky

BMI; coronary artery disease; cardiac CT;DISCHARGE Trial

Klíčová slova anglicky

BMI; coronary artery disease; cardiac CT;DISCHARGE Trial

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 27. 2. 2025 10:16, Bc. Hana Vladíková, BBA

Anotace

V originále

When patients suspected of having coronary artery disease were stratified by body mass index category, no difference in clinical outcomes was observed between those who underwent initial management with CT and those who underwent invasive coronary angiography. Background Recent trials support the role of cardiac CT in the evaluation of symptomatic patients suspected of having coronary artery disease (CAD); however, body mass index (BMI) has been reported to negatively impact CT image quality. Purpose To compare initial use of CT versus invasive coronary angiography (ICA) on clinical outcomes in patients with stable chest pain stratified by BMI category. Materials and Methods This prospective study represents a prespecified BMI subgroup analysis of the multicenter Diagnostic Imaging Strategies for Patients with Stable Chest Pain and Intermediate Risk of Coronary Artery Disease (DISCHARGE) trial conducted between October 2015 and April 2019. Adult patients with stable chest pain and a CAD pretest probability of 10%–60% were randomly assigned to undergo initial CT or ICA. The primary end point was major adverse cardiovascular events (MACE), including cardiovascular death, nonfatal myocardial infarction, or stroke. The secondary end point was an expanded MACE composite, including transient ischemic attack, and major procedure-related complications. Competing risk analyses were performed using the Fine and Gray subdistribution Cox proportional hazard model to assess the impact of the relationship between BMI and initial management with CT or ICA on the study outcomes, whereas noncardiovascular death and unknown causes of death were considered competing risk events.

Návaznosti

90249, velká výzkumná infrastruktura
Název: CZECRIN IV